Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

Twenty patients with relapsed B-ALL after HSCT were treated with CAR T cell therapy and were evaluated for efficacy and safety. Twelve patients previously received haploidentical transplantation, while 8 patients received HLA-matched transplantation. The median relapse time was 12 months (range, 4 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Lijuan, Wang, Yiyun, Hong, Ruimin, Zhao, Houli, Zhou, Linghui, Wei, Guoqing, Wu, Wenjun, Xu, Huijun, Zhang, Yanlei, Luo, Yi, Shi, Jimin, Chang, Alex H., Hu, Yongxian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591161/
https://www.ncbi.nlm.nih.gov/pubmed/34790576
http://dx.doi.org/10.3389/fonc.2021.750218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591161/
https://www.ncbi.nlm.nih.gov/pubmed/34790576
http://dx.doi.org/10.3389/fonc.2021.750218

Ejemplares similares